Abstract
Get full access to this article
View all access options for this article.
References
1.
Pfizer Inc. Q4 2021 Pfizer, Inc. Earnings Call, Edited Transcript. 2022. https://s28.q4cdn.com/781576035/files/doc_financials/2021/q4/PFE-USQ_Transcript_2022-02-08.pdf (last accessed
February 12 , 2022
).
2.CSL Behring . Final Analysis of Pivotal HOPE-B Study Demonstrates Durable and Sustained Therapeutic Effect of Etranacogene Dezaparvovec Gene Therapy in Hemophilia B—Data Presented at EAHAD 2022. 2022. https://www.cslbehring.com/newsroom/2022/hope-b-data-presented-at-eahad2022 (last accessed
February 12 , 2022
).
3.Intellia Therapeutics . Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics. 2022. https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-announces-acquisition-rewrite-therapeutics (last accessed
February 12 , 2022
).
4.Center for Breakthrough Medicines . The Center for Breakthrough Medicines and the University of Pennsylvania Partner in the Manufacturing of Gene Therapies. 2022. https://www.prnewswire.com/news-releases/the-center-for-breakthrough-medicines-and-the-university-of-pennsylvania-partner-in-the-manufacturing-of-gene-therapies-301462932.html?tc=eml_cleartime (last accessed
February 12 , 2022
).
5.Sarepta Therapeutics and GenEdit . Sarepta Therapeutics and GenEdit Share Progress on Research Collaboration and Announce Agreement to Develop Gene Editing Therapeutics for Neuromuscular Diseases. 2022. https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-and-genedit-share-progress-research (last accessed
February 12 , 2022
).
6.64x Bio . 64x Bio Raises $55 Million Series A Financing to Advance Cell Line Engineering Platform for Gene Therapy Manufacturing. 2022. https://www.businesswire.com/news/home/20220119005386/en/64x-Bio-Raises-55-Million-Series-A-Financing-to-Advance-Cell-Line-Engineering-Platform-for-Gene-Therapy-Manufacturing (last accessed
February 12 , 2022
).